Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer
“Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer”, vol. 13, pp. 5285-5291, 2014.
, This study aimed to investigate calcitonin as an effective therapy for osteoporosis in patients with bone pain during the anastrozole treatment of breast cancer. Ninety-one patients, who were on anastrozole treatment for breast cancer and also suffered anastrozole-induced bone pain, were randomly divided into two groups: the calcitonin group received salmon calcitonin and Caltrate D, and the control group received Caltrate D.